Inhibrx Biosciences, Inc. Common Stock vs. Repligen Corp
Inhibrx Biosciences, Inc. Common Stock and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| INBX | RGEN | |
|---|---|---|
| Market Cap | $1.41 billion | $11.16 billion |
RGEN leads on 1 of 1 size & scale factors.
Risk & Sentiment
| INBX | RGEN | |
|---|---|---|
| Short Interest | 1.44% | 7.13% |
INBX leads on 1 of 1 risk & sentiment factors.
Dig deeper: INBX overview, INBX financials, RGEN overview, RGEN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.